The overall ratings of seven Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
Google’s Turning Evil With Gmail
Google recently made changes to its much-adored Gmail service. But hiding ads among users emails is a bad business move, and users are speaking out. More
These Small Banks Have Big Potential
We're on the cusp of an M&A wave that will boost returns in small bank plays. Here's what to look for -- and how you can get involved. More
5 ETFs to Play Apple’s Big Rally
These five funds give you a big, low-cost dose of Apple stock exposure while also offering diversification across a number of other positions. More
Should I Buy AT&T? 3 Pros, 3 Cons
AT&T has gone a third straight quarter without truly exciting Wall Street with its earnings report and it's stock is listing lower. Does AT&T still deserve a pass? More
4 Packaged Foods Stocks to Buy Now
The grades of four Packaged Foods stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More
